Thiel Bio
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Seed, Early Stage, Series A, Series B, Growth, Late Stage, Pre-IPO
Geographical Focus
United States, United Kingdom, Canada, Germany, Israel
Industries Focus
- Healthcare
- Energy
- Consumer Goods
- Media
- Software
- FinTech
- Artificial Intelligence
- Aerospace
- Entertainment
- Biotechnology
- Hardware
- Defense
- FemTech
- Med-Tech
- Dual-Use Technology
Investment Size:
1,000,000 to 50,000,000 USD
Investor Details Founded: 2011
Thiel Bio is a venture capital firm investing in innovative biotechnology companies. The firm is based in West Hollywood, California, and operates as part of Thiel Capital, providing strategic and operational support for Peter Thiel's various investment initiatives and entrepreneurial endeavors. Thiel Bio focuses on early-stage investments in the biotechnology sector, aiming to support companies that are developing groundbreaking solutions in healthcare and related fields.
The firm's investment strategy encompasses a broad range of stages, including Seed, Early Stage, Series A, Series B, Growth, Late Stage, and Pre-IPO. Thiel Bio's geographical focus spans multiple countries, including the United States, Germany, the United Kingdom, Canada, and Israel. This global approach allows the firm to identify and support promising biotech companies worldwide.
Thiel Bio's portfolio includes a diverse array of companies across various industries, such as biotechnology, healthcare, med-tech, femtech, defense, aerospace, dual-use technology, fintech, energy, artificial intelligence, software, hardware, consumer goods, media, and entertainment. The firm typically invests between $1 million and $50 million in each portfolio company, reflecting its commitment to supporting companies at different stages of development and across a wide range of sectors within the biotechnology and related industries.
Requirements
- Innovative biotechnology solutions
- Strong management teams
- Scalable business models
- Potential for significant impact in healthcare and related fields
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
Portfolio Companies
- Alloy Therapeutics
- EnClear Therapies
- ATAI Life Sciences
- COMPASS Pathways
- Peptilogics
- Chemomab
- Pilgrim
- Rollup
- Advano
- Angiex
- Hugoboom
- Rhea
- Bullish Global
- FTX
- QA Wolf
- Neros
- Regent Craft
Claim this Investor
Are you an official representative of Thiel Bio?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim